Brief: Harpoon Therapeutics Presents Updated Interim Clinical Data For The Psma-Targeting Tritac® Hpn424 At The 2021 Asco Annual Meeting
04/06/2021 15:38
June 4 (Reuters) - Harpoon Therapeutics Inc HARP.O :
* HARPOON THERAPEUTICS PRESENTS UPDATED INTERIM CLINICAL
DATA FOR
THE PSMA-TARGETING TRITAC® HPN424 AT THE 2021 ASCO ANNUAL
MEETING
Source text for Eikon: ID:nGNX3s7BLl
Further company coverage: HARP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harpoon Therapeutics
See all newsBrief: Harpoon Therapeutics Receives 17 Additional Demands Seeking Disclosures in Proxy Statement
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals